2 completed, 2 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Unknown 2 |
Follow Taejoon Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chest CT Using Low-concentration Iodine Contrast Media Iohexol (320mgI/mL) with 120kVp, Iohexol (320mgI/mL) with 100kVp, Iohexol (270mgI/mL) with 100kVp - Pulmonary Disease | Phase 4 | Unknown | Jung Im Jung | 370 | 2023-11-24 | 2024-07-25 |
| Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease Fluorometholone 0.1% ophthalmic solution, Cyclosporine 0.05% eye drops - Dry Eye Disease (DED) | Phase 4 | Completed | Korea University Anam Hospital | 32 | 2022-09-01 | 2025-03-14 |
| Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients TJO-018 (HA 0.15%), Cyclosporine Ophthalmic Emulsion 0.05% standard therapy (CMC 0.5% add), TJO-018 (HA 0.15%) + Cyclosporine Ophthalmic Emulsion 0.05% - Dry Eye, Dry Eye Syndromes | Phase 4 | Completed | Taejoon Pharmaceutical Co., Ltd. | 438 | 2019-11-12 | 2022-06-08 |
| Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients. Xalost S, Xalatan, Taflotan-S - Glaucoma | Phase 4 | Unknown | Taejoon Pharmaceutical Co., Ltd. | 144 | 2018-12-19 | 2019-11-15 |
Dry Eye Syndromes (2) · Glaucoma (1) · Lung Diseases (1)
Cyclosporine (1) · Cyclosporins (1) · Fluorometholone (1) · Iohexol (1) · Latanoprost (1) · MCC protocol (1) · Ophthalmic Solutions (1) · Standard of Care (1)
South Korea (4)